Global and United States Antibacterial, Antiviral and Antifungal Nanocoatings Market Report & Forecast 2022-2028

• Description
• Table of Contents
• Table of Figures
• PDF Download

• Description
• Table of Contents
• Table of Figures
• PDF Download

Market Analysis and Insights: Global and United States Antibacterial, Antiviral and Antifungal Nanocoatings Market
This report focuses on global and United States Antibacterial, Antiviral and Antifungal Nanocoatings market, also covers the segmentation data of other regions in regional level and county level.

Due to the COVID-19 pandemic, the global Antibacterial, Antiviral and Antifungal Nanocoatings market size is estimated to be worth US$  million in 2022 and is forecast to a readjusted size of US$  million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, by Type, Graphene accounting for % of the Antibacterial, Antiviral and Antifungal Nanocoatings global market in 2021, is projected to value US$  million by 2028, growing at a revised % CAGR from 2022 to 2028. While by Application, Medical Facilities and Laboratories was the leading segment, accounting for over  percent market share in 2021, and altered to an  % CAGR throughout this forecast period.

In United States the Antibacterial, Antiviral and Antifungal Nanocoatings market size is expected to grow from US$  million in 2021 to US$  million by 2028, at a CAGR of % during the forecast period  2022-2028.

Global Antibacterial, Antiviral and Antifungal Nanocoatings Scope and Market Size
Antibacterial, Antiviral and Antifungal Nanocoatings market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Antibacterial, Antiviral and Antifungal Nanocoatings market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.

For United States market, this report focuses on the Antibacterial, Antiviral and Antifungal Nanocoatings market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.

Segment by Type
    Graphene
    Metal Oxide
    Carbon

Segment by Application
    Medical Facilities and Laboratories
    Medical Equipment
    Clothing Fabric
    Pharmaceutical Laboratory
    Package
    Food Packing Area and Restaurant

By Region
    North America
        United States
        Canada
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
    Asia-Pacific
        China
        Japan
        South Korea
        India
        Australia
        China Taiwan
        Indonesia
        Thailand
        Malaysia
    Latin America
        Mexico
        Brazil
        Argentina
        Colombia
    Middle East & Africa
        Turkey
        Saudi Arabia
        UAE

By Company
    Kastus
    Bio-Gate AG
    Covalon Technologies Ltd
    EnvisionSQ
    GrapheneCA
    Reactive Surfaces
    Nano Came Co. Ltd
    NanoTouch Materials, LLC
    NBD Nanotechnologies
    Green Earth Nano Science
    HeiQ Materials

 1 Study Coverage
    1.1 Antibacterial, Antiviral and Antifungal Nanocoatings Product Introduction
    1.2 Global Antibacterial, Antiviral and Antifungal Nanocoatings Outlook 2017 VS 2022 VS 2028
        1.2.1 Global Antibacterial, Antiviral and Antifungal Nanocoatings Sales in US$ Million for the Year 2017-2028
        1.2.2 Global Antibacterial, Antiviral and Antifungal Nanocoatings Sales in Volume for the Year 2017-2028
    1.3 United States Antibacterial, Antiviral and Antifungal Nanocoatings Outlook 2017 VS 2022 VS 2028
        1.3.1 United States Antibacterial, Antiviral and Antifungal Nanocoatings Sales in US$ Million for the Year 2017-2028
        1.3.2 United States Antibacterial, Antiviral and Antifungal Nanocoatings Sales in Volume for the Year 2017-2028
    1.4 Antibacterial, Antiviral and Antifungal Nanocoatings Market Size, United States VS Global, 2017 VS 2022 VS 2028
        1.4.1 The Market Share of United States Antibacterial, Antiviral and Antifungal Nanocoatings in Global, 2017 VS 2022 VS 2028
        1.4.2 The Growth Rate of Antibacterial, Antiviral and Antifungal Nanocoatings Market Size, United States VS Global, 2017 VS 2022 VS 2028
    1.5 Antibacterial, Antiviral and Antifungal Nanocoatings Market Dynamics
        1.5.1 Antibacterial, Antiviral and Antifungal Nanocoatings Industry Trends
        1.5.2 Antibacterial, Antiviral and Antifungal Nanocoatings Market Drivers
        1.5.3 Antibacterial, Antiviral and Antifungal Nanocoatings Market Challenges
        1.5.4 Antibacterial, Antiviral and Antifungal Nanocoatings Market Restraints
    1.6 Study Objectives
    1.7 Years Considered

 2 Market by Type
    2.1 Antibacterial, Antiviral and Antifungal Nanocoatings Market Segment by Type
        2.1.1 Graphene
        2.1.2 Metal Oxide
        2.1.3 Carbon
    2.2 Global Antibacterial, Antiviral and Antifungal Nanocoatings Market Size by Type
        2.2.1 Global Antibacterial, Antiviral and Antifungal Nanocoatings Sales in Value, by Type (2017, 2022 & 2028)
        2.2.2 Global Antibacterial, Antiviral and Antifungal Nanocoatings Sales in Volume, by Type (2017, 2022 & 2028)
        2.2.3 Global Antibacterial, Antiviral and Antifungal Nanocoatings Average Selling Price (ASP) by Type (2017, 2022 & 2028)
    2.3 United States Antibacterial, Antiviral and Antifungal Nanocoatings Market Size by Type
        2.3.1 United States Antibacterial, Antiviral and Antifungal Nanocoatings Sales in Value, by Type (2017, 2022 & 2028)
        2.3.2 United States Antibacterial, Antiviral and Antifungal Nanocoatings Sales in Volume, by Type (2017, 2022 & 2028)
        2.3.3 United States Antibacterial, Antiviral and Antifungal Nanocoatings Average Selling Price (ASP) by Type (2017, 2022 & 2028)

 3 Market by Application
    3.1 Antibacterial, Antiviral and Antifungal Nanocoatings Market Segment by Application
        3.1.1 Medical Facilities and Laboratories
        3.1.2 Medical Equipment
        3.1.3 Clothing Fabric
        3.1.4 Pharmaceutical Laboratory
        3.1.5 Package
        3.1.6 Food Packing Area and Restaurant
    3.2 Global Antibacterial, Antiviral and Antifungal Nanocoatings Market Size by Application
        3.2.1 Global Antibacterial, Antiviral and Antifungal Nanocoatings Sales in Value, by Application (2017, 2022 & 2028)
        3.2.2 Global Antibacterial, Antiviral and Antifungal Nanocoatings Sales in Volume, by Application (2017, 2022 & 2028)
        3.3.3 Global Antibacterial, Antiviral and Antifungal Nanocoatings Average Selling Price (ASP) by Application (2017, 2022 & 2028)
    3.3 United States Antibacterial, Antiviral and Antifungal Nanocoatings Market Size by Application
        3.3.1 United States Antibacterial, Antiviral and Antifungal Nanocoatings Sales in Value, by Application (2017, 2022 & 2028)
        3.3.2 United States Antibacterial, Antiviral and Antifungal Nanocoatings Sales in Volume, by Application (2017, 2022 & 2028)
        3.3.3 United States Antibacterial, Antiviral and Antifungal Nanocoatings Average Selling Price (ASP) by Application (2017, 2022 & 2028)

 4 Global Antibacterial, Antiviral and Antifungal Nanocoatings Competitor Landscape by Company
    4.1 Global Antibacterial, Antiviral and Antifungal Nanocoatings Market Size by Company
        4.1.1 Top Global Antibacterial, Antiviral and Antifungal Nanocoatings Manufacturers Ranked by Revenue (2021)
        4.1.2 Global Antibacterial, Antiviral and Antifungal Nanocoatings Revenue by Manufacturer (2017-2022)
        4.1.3 Global Antibacterial, Antiviral and Antifungal Nanocoatings Sales by Manufacturer (2017-2022)
        4.1.4 Global Antibacterial, Antiviral and Antifungal Nanocoatings Price by Manufacturer (2017-2022)
    4.2 Global Antibacterial, Antiviral and Antifungal Nanocoatings Concentration Ratio (CR)
        4.2.1 Antibacterial, Antiviral and Antifungal Nanocoatings Market Concentration Ratio (CR) (2017-2022)
        4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Antibacterial, Antiviral and Antifungal Nanocoatings in 2021
        4.2.3 Global Antibacterial, Antiviral and Antifungal Nanocoatings Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    4.3 Global Antibacterial, Antiviral and Antifungal Nanocoatings Manufacturing Base Distribution, Product Type
        4.3.1 Global Antibacterial, Antiviral and Antifungal Nanocoatings Manufacturers, Headquarters and Distribution of Producing Region
        4.3.2 Manufacturers Antibacterial, Antiviral and Antifungal Nanocoatings Product Type
        4.3.3 Date of International Manufacturers Enter into Antibacterial, Antiviral and Antifungal Nanocoatings Market
    4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
    4.5 United States Antibacterial, Antiviral and Antifungal Nanocoatings Market Size by Company
        4.5.1 Top Antibacterial, Antiviral and Antifungal Nanocoatings Players in United States, Ranked by Revenue (2021)
        4.5.2 United States Antibacterial, Antiviral and Antifungal Nanocoatings Revenue by Players (2020, 2021 & 2022)
        4.5.3 United States Antibacterial, Antiviral and Antifungal Nanocoatings Sales by Players (2020, 2021 & 2022)

 5 Global Antibacterial, Antiviral and Antifungal Nanocoatings Market Size by Region
    5.1 Global Antibacterial, Antiviral and Antifungal Nanocoatings Market Size by Region: 2017 VS 2022 VS 2028
    5.2 Global Antibacterial, Antiviral and Antifungal Nanocoatings Market Size in Volume by Region (2017-2028)
        5.2.1 Global Antibacterial, Antiviral and Antifungal Nanocoatings Sales in Volume by Region: 2017-2022
        5.2.2 Global Antibacterial, Antiviral and Antifungal Nanocoatings Sales in Volume Forecast by Region (2023-2028)
    5.3 Global Antibacterial, Antiviral and Antifungal Nanocoatings Market Size in Value by Region (2017-2028)
        5.3.1 Global Antibacterial, Antiviral and Antifungal Nanocoatings Sales in Value by Region: 2017-2022
        5.3.2 Global Antibacterial, Antiviral and Antifungal Nanocoatings Sales in Value by Region: 2023-2028

 6 Segment in Region Level & Country Level
    6.1 North America
        6.1.1 North America Antibacterial, Antiviral and Antifungal Nanocoatings Market Size YoY Growth 2017-2028
        6.1.2 North America Antibacterial, Antiviral and Antifungal Nanocoatings Market Facts & Figures by Country (2017, 2022 & 2028)
        6.1.3 United States
        6.1.4 Canada
    6.2 Asia-Pacific
        6.2.1 Asia-Pacific Antibacterial, Antiviral and Antifungal Nanocoatings Market Size YoY Growth 2017-2028
        6.2.2 Asia-Pacific Antibacterial, Antiviral and Antifungal Nanocoatings Market Facts & Figures by Region (2017, 2022 & 2028)
        6.2.3 China
        6.2.4 Japan
        6.2.5 South Korea
        6.2.6 India
        6.2.7 Australia
        6.2.8 China Taiwan
        6.2.9 Indonesia
        6.2.10 Thailand
        6.2.11 Malaysia
    6.3 Europe
        6.3.1 Europe Antibacterial, Antiviral and Antifungal Nanocoatings Market Size YoY Growth 2017-2028
        6.3.2 Europe Antibacterial, Antiviral and Antifungal Nanocoatings Market Facts & Figures by Country (2017, 2022 & 2028)
        6.3.3 Germany
        6.3.4 France
        6.3.5 U.K.
        6.3.6 Italy
        6.3.7 Russia
    6.4 Latin America
        6.4.1 Latin America Antibacterial, Antiviral and Antifungal Nanocoatings Market Size YoY Growth 2017-2028
        6.4.2 Latin America Antibacterial, Antiviral and Antifungal Nanocoatings Market Facts & Figures by Country (2017, 2022 & 2028)
        6.4.3 Mexico
        6.4.4 Brazil
        6.4.5 Argentina
        6.4.6 Colombia
    6.5 Middle East and Africa
        6.5.1 Middle East and Africa Antibacterial, Antiviral and Antifungal Nanocoatings Market Size YoY Growth 2017-2028
        6.5.2 Middle East and Africa Antibacterial, Antiviral and Antifungal Nanocoatings Market Facts & Figures by Country (2017, 2022 & 2028)
        6.5.3 Turkey
        6.5.4 Saudi Arabia
        6.5.5 UAE

 7 Company Profiles
    7.1 Kastus
        7.1.1 Kastus Corporation Information
        7.1.2 Kastus Description and Business Overview
        7.1.3 Kastus Antibacterial, Antiviral and Antifungal Nanocoatings Sales, Revenue and Gross Margin (2017-2022)
        7.1.4 Kastus Antibacterial, Antiviral and Antifungal Nanocoatings Products Offered
        7.1.5 Kastus Recent Development
    7.2 Bio-Gate AG
        7.2.1 Bio-Gate AG Corporation Information
        7.2.2 Bio-Gate AG Description and Business Overview
        7.2.3 Bio-Gate AG Antibacterial, Antiviral and Antifungal Nanocoatings Sales, Revenue and Gross Margin (2017-2022)
        7.2.4 Bio-Gate AG Antibacterial, Antiviral and Antifungal Nanocoatings Products Offered
        7.2.5 Bio-Gate AG Recent Development
    7.3 Covalon Technologies Ltd
        7.3.1 Covalon Technologies Ltd Corporation Information
        7.3.2 Covalon Technologies Ltd Description and Business Overview
        7.3.3 Covalon Technologies Ltd Antibacterial, Antiviral and Antifungal Nanocoatings Sales, Revenue and Gross Margin (2017-2022)
        7.3.4 Covalon Technologies Ltd Antibacterial, Antiviral and Antifungal Nanocoatings Products Offered
        7.3.5 Covalon Technologies Ltd Recent Development
    7.4 EnvisionSQ
        7.4.1 EnvisionSQ Corporation Information
        7.4.2 EnvisionSQ Description and Business Overview
        7.4.3 EnvisionSQ Antibacterial, Antiviral and Antifungal Nanocoatings Sales, Revenue and Gross Margin (2017-2022)
        7.4.4 EnvisionSQ Antibacterial, Antiviral and Antifungal Nanocoatings Products Offered
        7.4.5 EnvisionSQ Recent Development
    7.5 GrapheneCA
        7.5.1 GrapheneCA Corporation Information
        7.5.2 GrapheneCA Description and Business Overview
        7.5.3 GrapheneCA Antibacterial, Antiviral and Antifungal Nanocoatings Sales, Revenue and Gross Margin (2017-2022)
        7.5.4 GrapheneCA Antibacterial, Antiviral and Antifungal Nanocoatings Products Offered
        7.5.5 GrapheneCA Recent Development
    7.6 Reactive Surfaces
        7.6.1 Reactive Surfaces Corporation Information
        7.6.2 Reactive Surfaces Description and Business Overview
        7.6.3 Reactive Surfaces Antibacterial, Antiviral and Antifungal Nanocoatings Sales, Revenue and Gross Margin (2017-2022)
        7.6.4 Reactive Surfaces Antibacterial, Antiviral and Antifungal Nanocoatings Products Offered
        7.6.5 Reactive Surfaces Recent Development
    7.7 Nano Came Co. Ltd
        7.7.1 Nano Came Co. Ltd Corporation Information
        7.7.2 Nano Came Co. Ltd Description and Business Overview
        7.7.3 Nano Came Co. Ltd Antibacterial, Antiviral and Antifungal Nanocoatings Sales, Revenue and Gross Margin (2017-2022)
        7.7.4 Nano Came Co. Ltd Antibacterial, Antiviral and Antifungal Nanocoatings Products Offered
        7.7.5 Nano Came Co. Ltd Recent Development
    7.8 NanoTouch Materials, LLC
        7.8.1 NanoTouch Materials, LLC Corporation Information
        7.8.2 NanoTouch Materials, LLC Description and Business Overview
        7.8.3 NanoTouch Materials, LLC Antibacterial, Antiviral and Antifungal Nanocoatings Sales, Revenue and Gross Margin (2017-2022)
        7.8.4 NanoTouch Materials, LLC Antibacterial, Antiviral and Antifungal Nanocoatings Products Offered
        7.8.5 NanoTouch Materials, LLC Recent Development
    7.9 NBD Nanotechnologies
        7.9.1 NBD Nanotechnologies Corporation Information
        7.9.2 NBD Nanotechnologies Description and Business Overview
        7.9.3 NBD Nanotechnologies Antibacterial, Antiviral and Antifungal Nanocoatings Sales, Revenue and Gross Margin (2017-2022)
        7.9.4 NBD Nanotechnologies Antibacterial, Antiviral and Antifungal Nanocoatings Products Offered
        7.9.5 NBD Nanotechnologies Recent Development
    7.10 Green Earth Nano Science
        7.10.1 Green Earth Nano Science Corporation Information
        7.10.2 Green Earth Nano Science Description and Business Overview
        7.10.3 Green Earth Nano Science Antibacterial, Antiviral and Antifungal Nanocoatings Sales, Revenue and Gross Margin (2017-2022)
        7.10.4 Green Earth Nano Science Antibacterial, Antiviral and Antifungal Nanocoatings Products Offered
        7.10.5 Green Earth Nano Science Recent Development
    7.11 HeiQ Materials
        7.11.1 HeiQ Materials Corporation Information
        7.11.2 HeiQ Materials Description and Business Overview
        7.11.3 HeiQ Materials Antibacterial, Antiviral and Antifungal Nanocoatings Sales, Revenue and Gross Margin (2017-2022)
        7.11.4 HeiQ Materials Antibacterial, Antiviral and Antifungal Nanocoatings Products Offered
        7.11.5 HeiQ Materials Recent Development

 8 Industry Chain and Sales Channels Analysis
    8.1 Antibacterial, Antiviral and Antifungal Nanocoatings Industry Chain Analysis
    8.2 Antibacterial, Antiviral and Antifungal Nanocoatings Key Raw Materials
        8.2.1 Key Raw Materials
        8.2.2 Antibacterial, Antiviral and Antifungal Nanocoatings Distributors
    8.3 Antibacterial, Antiviral and Antifungal Nanocoatings Production Mode & Process
    8.4 Antibacterial, Antiviral and Antifungal Nanocoatings Sales and Marketing
        8.4.1 Antibacterial, Antiviral and Antifungal Nanocoatings Sales Channels
        8.4.2 Antibacterial, Antiviral and Antifungal Nanocoatings Distributors
    8.5 Antibacterial, Antiviral and Antifungal Nanocoatings Customers

 9 Research Findings and Conclusion

 10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
        10.1.2 Data Source
    10.2 Author Details
    10.3 Disclaimer

List of Tables
    Table 1. Antibacterial, Antiviral and Antifungal Nanocoatings CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
    Table 2. Antibacterial, Antiviral and Antifungal Nanocoatings Market Trends
    Table 3. Antibacterial, Antiviral and Antifungal Nanocoatings Market Drivers
    Table 4. Antibacterial, Antiviral and Antifungal Nanocoatings Market Challenges
    Table 5. Antibacterial, Antiviral and Antifungal Nanocoatings Market Restraints
    Table 6. Global Antibacterial, Antiviral and Antifungal Nanocoatings Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Antibacterial, Antiviral and Antifungal Nanocoatings Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Antibacterial, Antiviral and Antifungal Nanocoatings Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Antibacterial, Antiviral and Antifungal Nanocoatings Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Antibacterial, Antiviral and Antifungal Nanocoatings Manufacturers in Global Market, Ranking by Revenue (2021)
    Table 11. Global Antibacterial, Antiviral and Antifungal Nanocoatings Revenue by Manufacturer, (US$ Million), 2017-2022
    Table 12. Global Antibacterial, Antiviral and Antifungal Nanocoatings Revenue Share by Manufacturer, 2017-2022
    Table 13. Global Antibacterial, Antiviral and Antifungal Nanocoatings Sales by Manufacturer, (Tons), 2017-2022
    Table 14. Global Antibacterial, Antiviral and Antifungal Nanocoatings Sales Share by Manufacturer, 2017-2022
    Table 15. Global Antibacterial, Antiviral and Antifungal Nanocoatings Price by Manufacturer (2017-2022) & (US$/Ton)
    Table 16. Global Antibacterial, Antiviral and Antifungal Nanocoatings Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global Antibacterial, Antiviral and Antifungal Nanocoatings by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antibacterial, Antiviral and Antifungal Nanocoatings as of 2021)
    Table 18. Top Players of Antibacterial, Antiviral and Antifungal Nanocoatings in Global Market, Headquarters and Distribution of Producing Region
    Table 19. Manufacturers Antibacterial, Antiviral and Antifungal Nanocoatings Product Type
    Table 20. Date of International Manufacturers Enter into Antibacterial, Antiviral and Antifungal Nanocoatings Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Top Antibacterial, Antiviral and Antifungal Nanocoatings Players in United States Market, Ranking by Revenue (2021)
    Table 23. United States Antibacterial, Antiviral and Antifungal Nanocoatings Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 24. United States Antibacterial, Antiviral and Antifungal Nanocoatings Revenue Share by Players, 2020, 2021 & 2022
    Table 25. United States Antibacterial, Antiviral and Antifungal Nanocoatings Sales by Players, (Tons), 2020, 2021 & 2022
    Table 26. United States Antibacterial, Antiviral and Antifungal Nanocoatings Sales Share by Players, 2020, 2021 & 2022
    Table 27. Global Antibacterial, Antiviral and Antifungal Nanocoatings Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 28. Global Antibacterial, Antiviral and Antifungal Nanocoatings Sales in Volume by Region (2017-2022) & (Tons)
    Table 29. Global Antibacterial, Antiviral and Antifungal Nanocoatings Sales in Volume Forecast by Region (2023-2028) & (Tons)
    Table 30. Global Antibacterial, Antiviral and Antifungal Nanocoatings Sales in Value by Region (2017-2022) & (US$ Million)
    Table 31. Global Antibacterial, Antiviral and Antifungal Nanocoatings Sales in Value Forecast by Region (2023-2028) & (US$ Million)
    Table 32. North America Antibacterial, Antiviral and Antifungal Nanocoatings Sales in Volume by Country (2017-2028) & (Tons)
    Table 33. North America Antibacterial, Antiviral and Antifungal Nanocoatings Sales in Value by Country (2017-2028) & (US$ Million)
    Table 34. Asia Pacific Antibacterial, Antiviral and Antifungal Nanocoatings Sales in Volume by Region (2017-2028) & (Tons)
    Table 35. Asia Pacific Antibacterial, Antiviral and Antifungal Nanocoatings Sales in Value by Region (2017-2028) & (US$ Million)
    Table 36. Europe Antibacterial, Antiviral and Antifungal Nanocoatings Sales in Volume by Country (2017-2028) & (Tons)
    Table 37. Europe Antibacterial, Antiviral and Antifungal Nanocoatings Sales in Value by Country (2017-2028) & (US$ Million)
    Table 38. Latin America Antibacterial, Antiviral and Antifungal Nanocoatings Sales in Volume by Country (2017-2028) & (Tons)
    Table 39. Latin Americaa Antibacterial, Antiviral and Antifungal Nanocoatings Sales in Value by Country (2017-2028) & (US$ Million)
    Table 40. Middle East and Africa Antibacterial, Antiviral and Antifungal Nanocoatings Sales in Volume by Country (2017-2028) & (Tons)
    Table 41. Middle East and Africa Antibacterial, Antiviral and Antifungal Nanocoatings Sales in Value by Country (2017-2028) & (US$ Million)
    Table 42. Kastus Corporation Information
    Table 43. Kastus Description and Business Overview
    Table 44. Kastus Antibacterial, Antiviral and Antifungal Nanocoatings Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
    Table 45. Kastus Antibacterial, Antiviral and Antifungal Nanocoatings Product
    Table 46. Kastus Recent Development
    Table 47. Bio-Gate AG Corporation Information
    Table 48. Bio-Gate AG Description and Business Overview
    Table 49. Bio-Gate AG Antibacterial, Antiviral and Antifungal Nanocoatings Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
    Table 50. Bio-Gate AG Product
    Table 51. Bio-Gate AG Recent Development
    Table 52. Covalon Technologies Ltd Corporation Information
    Table 53. Covalon Technologies Ltd Description and Business Overview
    Table 54. Covalon Technologies Ltd Antibacterial, Antiviral and Antifungal Nanocoatings Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
    Table 55. Covalon Technologies Ltd Product
    Table 56. Covalon Technologies Ltd Recent Development
    Table 57. EnvisionSQ Corporation Information
    Table 58. EnvisionSQ Description and Business Overview
    Table 59. EnvisionSQ Antibacterial, Antiviral and Antifungal Nanocoatings Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
    Table 60. EnvisionSQ Product
    Table 61. EnvisionSQ Recent Development
    Table 62. GrapheneCA Corporation Information
    Table 63. GrapheneCA Description and Business Overview
    Table 64. GrapheneCA Antibacterial, Antiviral and Antifungal Nanocoatings Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
    Table 65. GrapheneCA Product
    Table 66. GrapheneCA Recent Development
    Table 67. Reactive Surfaces Corporation Information
    Table 68. Reactive Surfaces Description and Business Overview
    Table 69. Reactive Surfaces Antibacterial, Antiviral and Antifungal Nanocoatings Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
    Table 70. Reactive Surfaces Product
    Table 71. Reactive Surfaces Recent Development
    Table 72. Nano Came Co. Ltd Corporation Information
    Table 73. Nano Came Co. Ltd Description and Business Overview
    Table 74. Nano Came Co. Ltd Antibacterial, Antiviral and Antifungal Nanocoatings Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
    Table 75. Nano Came Co. Ltd Product
    Table 76. Nano Came Co. Ltd Recent Development
    Table 77. NanoTouch Materials, LLC Corporation Information
    Table 78. NanoTouch Materials, LLC Description and Business Overview
    Table 79. NanoTouch Materials, LLC Antibacterial, Antiviral and Antifungal Nanocoatings Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
    Table 80. NanoTouch Materials, LLC Product
    Table 81. NanoTouch Materials, LLC Recent Development
    Table 82. NBD Nanotechnologies Corporation Information
    Table 83. NBD Nanotechnologies Description and Business Overview
    Table 84. NBD Nanotechnologies Antibacterial, Antiviral and Antifungal Nanocoatings Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
    Table 85. NBD Nanotechnologies Product
    Table 86. NBD Nanotechnologies Recent Development
    Table 87. Green Earth Nano Science Corporation Information
    Table 88. Green Earth Nano Science Description and Business Overview
    Table 89. Green Earth Nano Science Antibacterial, Antiviral and Antifungal Nanocoatings Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
    Table 90. Green Earth Nano Science Product
    Table 91. Green Earth Nano Science Recent Development
    Table 92. HeiQ Materials Corporation Information
    Table 93. HeiQ Materials Description and Business Overview
    Table 94. HeiQ Materials Antibacterial, Antiviral and Antifungal Nanocoatings Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
    Table 95. HeiQ Materials Product
    Table 96. HeiQ Materials Recent Development
    Table 97. Key Raw Materials Lists
    Table 98. Raw Materials Key Suppliers Lists
    Table 99. Antibacterial, Antiviral and Antifungal Nanocoatings Customers List
    Table 100. Antibacterial, Antiviral and Antifungal Nanocoatings Distributors List
    Table 101. Research Programs/Design for This Report
    Table 102. Key Data Information from Secondary Sources
    Table 103. Key Data Information from Primary Sources
List of Figures
    Figure 1. Antibacterial, Antiviral and Antifungal Nanocoatings Product Picture
    Figure 2. Global Antibacterial, Antiviral and Antifungal Nanocoatings Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Antibacterial, Antiviral and Antifungal Nanocoatings Market Size 2017-2028 (US$ Million)
    Figure 4. Global Antibacterial, Antiviral and Antifungal Nanocoatings Sales 2017-2028 (Tons)
    Figure 5. United States Antibacterial, Antiviral and Antifungal Nanocoatings Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 6. United States Antibacterial, Antiviral and Antifungal Nanocoatings Market Size 2017-2028 (US$ Million)
    Figure 7. United States Antibacterial, Antiviral and Antifungal Nanocoatings Sales 2017-2028 (Tons)
    Figure 8. United States Antibacterial, Antiviral and Antifungal Nanocoatings Market Share in Global, in Value (US$ Million) 2017-2028
    Figure 9. United States Antibacterial, Antiviral and Antifungal Nanocoatings Market Share in Global, in Volume (Tons) 2017-2028
    Figure 10. Antibacterial, Antiviral and Antifungal Nanocoatings Report Years Considered
    Figure 11. Product Picture of Graphene
    Figure 12. Product Picture of Metal Oxide
    Figure 13. Product Picture of Carbon
    Figure 14. Global Antibacterial, Antiviral and Antifungal Nanocoatings Market Share by Type in 2022 & 2028
    Figure 15. Global Antibacterial, Antiviral and Antifungal Nanocoatings Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 16. Global Antibacterial, Antiviral and Antifungal Nanocoatings Sales Market Share in Value by Type (2017-2028)
    Figure 17. Global Antibacterial, Antiviral and Antifungal Nanocoatings Sales by Type (2017-2028) & (Tons)
    Figure 18. Global Antibacterial, Antiviral and Antifungal Nanocoatings Sales Market Share in Volume by Type (2017-2028)
    Figure 19. Global Antibacterial, Antiviral and Antifungal Nanocoatings Price by Type (2017-2028) & (US$/Ton)
    Figure 20. United States Antibacterial, Antiviral and Antifungal Nanocoatings Market Share by Type in 2022 & 2028
    Figure 21. United States Antibacterial, Antiviral and Antifungal Nanocoatings Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 22. United States Antibacterial, Antiviral and Antifungal Nanocoatings Sales Market Share in Value by Type (2017-2028)
    Figure 23. United States Antibacterial, Antiviral and Antifungal Nanocoatings Sales by Type (2017-2028) & (Tons)
    Figure 24. United States Antibacterial, Antiviral and Antifungal Nanocoatings Sales Market Share in Volume by Type (2017-2028)
    Figure 25. United States Antibacterial, Antiviral and Antifungal Nanocoatings Price by Type (2017-2028) & (US$/Ton)
    Figure 26. Product Picture of Medical Facilities and Laboratories
    Figure 27. Product Picture of Medical Equipment
    Figure 28. Product Picture of Clothing Fabric
    Figure 29. Product Picture of Pharmaceutical Laboratory
    Figure 30. Product Picture of Package
    Figure 31. Product Picture of Food Packing Area and Restaurant
    Figure 32. Global Antibacterial, Antiviral and Antifungal Nanocoatings Market Share by Application in 2022 & 2028
    Figure 33. Global Antibacterial, Antiviral and Antifungal Nanocoatings Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 34. Global Antibacterial, Antiviral and Antifungal Nanocoatings Sales Market Share in Value by Application (2017-2028)
    Figure 35. Global Antibacterial, Antiviral and Antifungal Nanocoatings Sales by Application (2017-2028) & (Tons)
    Figure 36. Global Antibacterial, Antiviral and Antifungal Nanocoatings Sales Market Share in Volume by Application (2017-2028)
    Figure 37. Global Antibacterial, Antiviral and Antifungal Nanocoatings Price by Application (2017-2028) & (US$/Ton)
    Figure 38. United States Antibacterial, Antiviral and Antifungal Nanocoatings Market Share by Application in 2022 & 2028
    Figure 39. United States Antibacterial, Antiviral and Antifungal Nanocoatings Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 40. United States Antibacterial, Antiviral and Antifungal Nanocoatings Sales Market Share in Value by Application (2017-2028)
    Figure 41. United States Antibacterial, Antiviral and Antifungal Nanocoatings Sales by Application (2017-2028) & (Tons)
    Figure 42. United States Antibacterial, Antiviral and Antifungal Nanocoatings Sales Market Share in Volume by Application (2017-2028)
    Figure 43. United States Antibacterial, Antiviral and Antifungal Nanocoatings Price by Application (2017-2028) & (US$/Ton)
    Figure 44. North America Antibacterial, Antiviral and Antifungal Nanocoatings Sales in Volume Growth Rate 2017-2028 (Tons)
    Figure 45. North America Antibacterial, Antiviral and Antifungal Nanocoatings Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 46. United States Antibacterial, Antiviral and Antifungal Nanocoatings Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 47. Canada Antibacterial, Antiviral and Antifungal Nanocoatings Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 48. Europe Antibacterial, Antiviral and Antifungal Nanocoatings Sales in Volume Growth Rate 2017-2028 (Tons)
    Figure 49. Europe Antibacterial, Antiviral and Antifungal Nanocoatings Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 50. Germany Antibacterial, Antiviral and Antifungal Nanocoatings Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 51. France Antibacterial, Antiviral and Antifungal Nanocoatings Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 52. U.K. Antibacterial, Antiviral and Antifungal Nanocoatings Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 53. Italy Antibacterial, Antiviral and Antifungal Nanocoatings Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 54. Russia Antibacterial, Antiviral and Antifungal Nanocoatings Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 55. Asia-Pacific Antibacterial, Antiviral and Antifungal Nanocoatings Sales in Volume Growth Rate 2017-2028 (Tons)
    Figure 56. Asia-Pacific Antibacterial, Antiviral and Antifungal Nanocoatings Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 57. China Antibacterial, Antiviral and Antifungal Nanocoatings Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 58. Japan Antibacterial, Antiviral and Antifungal Nanocoatings Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 59. South Korea Antibacterial, Antiviral and Antifungal Nanocoatings Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 60. India Antibacterial, Antiviral and Antifungal Nanocoatings Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 61. Australia Antibacterial, Antiviral and Antifungal Nanocoatings Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 62. China Taiwan Antibacterial, Antiviral and Antifungal Nanocoatings Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 63. Indonesia Antibacterial, Antiviral and Antifungal Nanocoatings Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 64. Thailand Antibacterial, Antiviral and Antifungal Nanocoatings Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 65. Malaysia Antibacterial, Antiviral and Antifungal Nanocoatings Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 66. Latin America Antibacterial, Antiviral and Antifungal Nanocoatings Sales in Volume Growth Rate 2017-2028 (Tons)
    Figure 67. Latin America Antibacterial, Antiviral and Antifungal Nanocoatings Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 68. Mexico Antibacterial, Antiviral and Antifungal Nanocoatings Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 69. Brazil Antibacterial, Antiviral and Antifungal Nanocoatings Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 70. Argentina Antibacterial, Antiviral and Antifungal Nanocoatings Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 71. Colombia Antibacterial, Antiviral and Antifungal Nanocoatings Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 72. Middle East & Africa Antibacterial, Antiviral and Antifungal Nanocoatings Sales in Volume Growth Rate 2017-2028 (Tons)
    Figure 73. Middle East & Africa Antibacterial, Antiviral and Antifungal Nanocoatings Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 74. Turkey Antibacterial, Antiviral and Antifungal Nanocoatings Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 75. Saudi Arabia Antibacterial, Antiviral and Antifungal Nanocoatings Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 76. UAE Antibacterial, Antiviral and Antifungal Nanocoatings Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 77. Antibacterial, Antiviral and Antifungal Nanocoatings Value Chain
    Figure 78. Antibacterial, Antiviral and Antifungal Nanocoatings Production Process
    Figure 79. Channels of Distribution
    Figure 80. Distributors Profiles
    Figure 81. Bottom-up and Top-down Approaches for This Report
    Figure 82. Data Triangulation
    Figure 83. Key Executives Interviewed

Market Analysis and Insights: Global and United States Antibacterial, Antiviral and Antifungal Nanocoatings Market
This report focuses on global and United States Antibacterial, Antiviral and Antifungal Nanocoatings market, also covers the segmentation data of other regions in regional level and county level.

Due to the COVID-19 pandemic, the global Antibacterial, Antiviral and Antifungal Nanocoatings market size is estimated to be worth US$  million in 2022 and is forecast to a readjusted size of US$  million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, by Type, Graphene accounting for % of the Antibacterial, Antiviral and Antifungal Nanocoatings global market in 2021, is projected to value US$  million by 2028, growing at a revised % CAGR from 2022 to 2028. While by Application, Medical Facilities and Laboratories was the leading segment, accounting for over  percent market share in 2021, and altered to an  % CAGR throughout this forecast period.

In United States the Antibacterial, Antiviral and Antifungal Nanocoatings market size is expected to grow from US$  million in 2021 to US$  million by 2028, at a CAGR of % during the forecast period  2022-2028.

Global Antibacterial, Antiviral and Antifungal Nanocoatings Scope and Market Size
Antibacterial, Antiviral and Antifungal Nanocoatings market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Antibacterial, Antiviral and Antifungal Nanocoatings market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.

For United States market, this report focuses on the Antibacterial, Antiviral and Antifungal Nanocoatings market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.

Segment by Type
    Graphene
    Metal Oxide
    Carbon

Segment by Application
    Medical Facilities and Laboratories
    Medical Equipment
    Clothing Fabric
    Pharmaceutical Laboratory
    Package
    Food Packing Area and Restaurant

By Region
    North America
        United States
        Canada
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
    Asia-Pacific
        China
        Japan
        South Korea
        India
        Australia
        China Taiwan
        Indonesia
        Thailand
        Malaysia
    Latin America
        Mexico
        Brazil
        Argentina
        Colombia
    Middle East & Africa
        Turkey
        Saudi Arabia
        UAE

By Company
    Kastus
    Bio-Gate AG
    Covalon Technologies Ltd
    EnvisionSQ
    GrapheneCA
    Reactive Surfaces
    Nano Came Co. Ltd
    NanoTouch Materials, LLC
    NBD Nanotechnologies
    Green Earth Nano Science
    HeiQ Materials